biology

Regenerative medicine advanced therapy

Regenerative medicine advanced therapy is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Regenerative medicine advanced therapy rather than just read about it. In short: Regenerative Medicine Advanced Therapy (RMAT) is a designation given by the Food and Drug Administration to drug candidates intended to treat serious or life-threatening conditions under the 21st Century Cures Act. A RMAT designation allows for accelerated approval based surrogate or intermediate endpoints.

Key takeaways

Regenerative medicine advanced therapy belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Regenerative medicine advanced therapy to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Regenerative medicine advanced therapy from memory before moving on to harder problems.

Reference excerpt

Regenerative Medicine Advanced Therapy (RMAT) is a designation given by the Food and Drug Administration to drug candidates intended to treat serious or life-threatening conditions under the 21st Century Cures Act. A RMAT designation allows for accelerated approval based surrogate or intermediate endpoints. RMAT goes beyond breakthrough therapy features by allowing for accelerated approval of drugs based on surrogate endpoints. A surrogate endpoint is a biomarker that substitutes for a direct endpoint, such as clinical benefit.

Legal background Section 3033 of the 21st Century Cures Act introduces section 506(g) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) that allows for the designation of certain therapies as a 'regenerative medicine advanced therapy' (RMAT) (21 U.S.C. § 356).

Qualifying criteria In order to qualify for RMAT status, a treatment must

meet the definition of a regenerative medicine therapy, intend to treat, modify, reverse or cure a serious condition, and be supported by preliminary clinical evidence that indicates the RMAT candidate can address the clinical need. A regenerative medicine therapy is defined in section 506(g)(8) of the FD&C Act to include cell therapies, therapeutic tissue engineering, human cell and tissue products. Under the FDA's interpretation, gene therapies and genetically modified cells that have a lasting effect, such as CAR-T antitumor therapies, may also qualify as regenerative medicine therapies.

Effect A RMAT designation includes all benefits of the Fast Track and breakthrough therapy designations. In addition, it opens up early interactions between the FDA and sponsors to facilitate accelerated approval. In this context, accelerated approval means approval based on

previously agreed-upon surrogate or intermediate endpoints, or data from a limited but meaningful number of sites. The ability to use 'Real World Evidence' (RWE), i.e. post-market evidence of safety and effectiveness, is particularly useful in the context of orphan diseases, where recruiting a sufficiently large cohort for pre-marketing clinical trials may not be feasible. RWE may include data from patient registries, clinical records and case studies. Where a RMAT's sponsor fails to comply with the requirements for accelerated approval, the RMAT designation and the benefits conferred by it can be withdrawn (21 CFR 601.43).

Examples

Statistics In 2020, the FDA received 34 requests for RMAT status, of which 12 (35.3%) were granted. RMAT designated drugs include the novel CAR-T therapy Kymriah and betibeglogene autotemcel for beta thalassemia. As of 31 March 2021, 62 requests for RMAT status have been granted. More than half of the RMAT applications received by March 2019 involved autologous or allogeneic cell therapy products, including CAR-T therapies.

See also Breakthrough therapy Advanced Therapy Medicinal Product (European Medicines Agency equivalent) Sakigake (Japanese equivalent) Orphan drug

References

Worked examples

Example 1 — a first encounter with Regenerative medicine advanced therapy

Start with the simplest possible case. Write down what Regenerative medicine advanced therapy claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Regenerative medicine advanced therapy before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Regenerative medicine advanced therapy ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Regenerative medicine advanced therapy

In research: Regenerative medicine advanced therapy appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Regenerative medicine advanced therapy in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Regenerative medicine advanced therapy is common in secondary-school and first-year university syllabi. It links to neighbouring topics Food and Drug Administration, Pharmaceuticals policy, Pharmacy, so understanding it makes those chapters shorter.
In everyday life: Look for Regenerative medicine advanced therapy outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Regenerative medicine advanced therapy” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Regenerative medicine advanced therapy in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Regenerative medicine advanced therapy means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Regenerative medicine advanced therapy out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Regenerative medicine advanced therapy in simple terms?

Why does Regenerative medicine advanced therapy matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Regenerative medicine advanced therapy?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Regenerative medicine advanced therapy.